Treatment of steroid-dependent bronchial asthma with cyclosporin.

No abstract is available for this paper.

• Publication year

  1995

• Venue

  European Respiratory Journal

• Publication date

  1995-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1183/09031936.95.08071091PMID 7589392
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The mechanism of action of cyclosporin A and FK506.

  1996influential reference
• Pharmacological Agents in Bronchial Provocation Tests

  1993cited by this paper
• Risk factors for cyclosporine-induced nephropathy in patients with autoimmune diseases. International Kidney Biopsy Registry of Cyclosporine in Autoimmune Diseases.

  1992cited by this paper
• Trial of cyclosporin in corticosteroid-dependent chronic severe asthma.

  1992cited by this paper
• The mechanism of action of cyclosporin A and FK506.

  1992influential reference
• Is there a role for cyclosporine in asthma?

  1992cited by this paper
• Do we know the site of action of cyclosporin?

  1992cited by this paper
• Protective effects of cyclophosphamide, cyclosporin A and FK506 against antigen‐induced lung eosinophilia in guinea‐pigs

  1992cited by this paper
• Auranofin in the treatment of steroid dependent asthma: a double blind study.

  1992cited by this paper
• Cyclosporin and asthma.

  1992cited by this paper
• Effect of dexamethasone and cyclosporin A on allergen-induced airway hyperresponsiveness and inflammatory cell responses in sensitized Brown-Norway rats.

  1992cited by this paper
• Asthma. New therapeutic approaches.

  1992cited by this paper
• Cyclosporin in chronic severe asthma

  1992cited by this paper
• Serum creatinine or glomerular filtration rate for monitoring cyclosporin therapy.

  1991cited by this paper
• [Cyclosporine A inhibits allergen-induced late asthmatic response and increase of airway hyperresponsiveness in guinea pigs].

  1991cited by this paper
• The effect of dapsone in steroid-dependent asthma.

  1991cited by this paper
• High-dose beclomethasone: oral steroid-sparing effect in severe asthmatic patients.

  1991cited by this paper
• Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes.

  1991cited by this paper
• Glucocorticoid resistance in chronic asthma. Peripheral blood T lymphocyte activation and comparison of the T lymphocyte inhibitory effects of glucocorticoids and cyclosporin A.

  1991cited by this paper
• Cyclosporine for plaque-type psoriasis. Results of a multidose, double-blind trial.

  1991cited by this paper
• Double-blind, controlled, crossover study of cyclosporin in adults with severe refractory atopic dermatitis.

  1991cited by this paper
• Cyclosporin for a severe case of aspirin-induced asthma.

  1991cited by this paper
• Cyclosporin for steroid‐dependent asthma

  1991cited by this paper
• Lymphokine gene expression in vivo is inhibited by cyclosporin A

  1990cited by this paper
• Tolerance to reduction of oral steroid dosage in severely asthmatic patients receiving nedocromil sodium.

  1990cited by this paper
• Low-dose cyclosporin versus placebo in patients with rheumatoid arthritis.

  1990cited by this paper
• Randomised, double-blind, placebo-controlled trial of methotrexate in steroid-dependent asthma.

  1990cited by this paper
• CD4 T-lymphocyte activation in acute severe asthma. Relationship to disease severity and atopic status.

  1990cited by this paper
• Assessment of bronchial responsiveness as a guide to prognosis and therapy in asthma.

  1990cited by this paper
• Cyclosporin A inhibits degranulation of rat basophilic leukemia cells and human basophils. Inhibition of mediator release without affecting PI hydrolysis or Ca2+ fluxes.

  1990cited by this paper
• Inhibition of histamine and prostaglandin D2 release from human lung mast cells by ciclosporin A.

  1989cited by this paper
• Methotrexate in the treatment of corticosteroid-dependent asthma. A double-blind crossover study.

  1988cited by this paper
• An improved protocol for the use of troleandomycin (TAO) in the treatment of steroid-requiring asthma.

  1986cited by this paper
• An evaluation of azathioprine in severe chronic asthma

  1971cited by this paper

• Use of Text Data in Identifying and Prioritizing Potential Drug Repositioning Candidates

  2019cites this paper
• Notes from the Chair

  2019cites this paper
• Inadequate assessment of adherence to maintenance medication leads to loss of power and increased costs in trials of severe asthma therapy: results from a systematic literature review and modelling study

  2019cites this paper
• Gúıa de diagnóstico y tratamiento del asma de control dif́ıcil en el niño

  2018cites this paper
• Self‐micellizing solid dispersion of cyclosporine A for pulmonary delivery: Physicochemical, pharmacokinetic and safety assessments

  2017cites this paper
• 18β-Glycyrrhetinic acid, the major bioactive component of Glycyrrhizae Radix, attenuates airway inflammation by modulating Th2 cytokines, GATA-3, STAT6, and Foxp3 transcription factors in an asthmatic mouse model.

  2017cites this paper
• MESA REDONDA. ASMA DE DIFÍCIL CONTROL

  2016cites this paper
• Anti‐inflammatory effects of intranasal cyclosporine for allergic rhinitis in a mouse model

  2016cites this paper
• Gu´ ia de diagny tratamiento del asma de control dif´ icil en el nino

  2016cites this paper
• Gu´õa de diagny tratamiento del asma de control dif´õcil en el nino

  2016cites this paper
• The Role and Immunobiology of Eosinophils in the Respiratory System: a Comprehensive Review

  2016cites this paper
• candidates extracted by literature-based discovery

  2015cites this paper
• A new method for prioritizing drug repositioning candidates extracted by literature-based discovery

  2015cites this paper
• Oleanolic acid suppresses ovalbumin-induced airway inflammation and Th2-mediated allergic asthma by modulating the transcription factors T-bet, GATA-3, RORγt and Foxp3 in asthmatic mice.

  2014cites this paper
• Pulmonary , gastrointestinal and urogenital pharmacology Ursolic acid , a potential PPAR g agonist , suppresses ovalbumin-induced airway inflammation and Penh by down-regulating IL-5 , IL-13 , and IL-17 in a mouse model of allergic asthma

  2013cites this paper
• [Targeted therapies in severe asthma: the discovery of new molecules].

  2013cites this paper
• [Strategic formulation study on dry powder inhalation system based on modulated molecular properties and controlled pharmacokinetics].

  2013cites this paper
• Immunologic therapeutic interventions in asthma: impact on natural history.

  2012cites this paper
• Bronchial asthma developing after 15 years of immunosuppressive treatment following renal transplantation.

  2012cites this paper
• Aspirin-Sensitive Asthma

  2012cites this paper
• Drug Treatment of Asthma in the 1990s

  2012cites this paper
• Unconventional treatment options in severe asthma: an overivew.

  2011cites this paper
• Rationale for the use of immunomodulatory therapies in the Global Initiative for Asthma (GINA) step V asthma other than oral glucocorticosteroids

  2011cites this paper
• Effect of cyclosporine on blood pressure.

  2010cites this paper
• Recommendation for optimal management of severe refractory asthma

  2010cites this paper
• CHAPTER 41 – New Insight into the Pathogenesis and Management of Refractory Childhood Asthma

  2010cites this paper
• Improved dissolution and pharmacokinetic behavior of cyclosporine A using high-energy amorphous solid dispersion approach.

  2010cites this paper
• Managing patients with chronic severe asthma: rise to the challenge.

  2009cites this paper
• Interferon-α als Therapieoption bei der Behandlung des schwergradig persistierenden, unkontrollierten Asthma bronchiale: Eine offene Studie

  2009cites this paper
• [Diagnosis and treatment guidelines for difficult-to-control asthma in children].

  2009cites this paper
• Masitinib, a c‐kit/PDGF receptor tyrosine kinase inhibitor, improves disease control in severe corticosteroid‐dependent asthmatics

  2009cites this paper
• A Case Report Of Aspirin-Iinduced Asthma (AIA) Syndrome After Ingestion Of Naproxen

  2009cites this paper
• Guía de diagnóstico y tratamiento del asma de control difícil en el niño

  2009cites this paper
• In vitro and in vivo characterization on amorphous solid dispersion of cyclosporine A for inhalation therapy.

  2009cites this paper
• Thérapeutiques immunologiques ciblées dans l’asthme sévère

  2008cites this paper
• An overview of chronic severe asthma

  2008cites this paper
• Immunomodulatory and biologic therapies for severe refractory asthma.

  2008influential citation
• [Targeted immunologic therapies for severe asthma].

  2008cites this paper
• Severe asthma: approach and management

  2008cites this paper
• Oral corticosteroid-dependent asthma: a 30-year review.

  2007cites this paper
• Immunosuppressive Therapy Does Not Prevent the Occurrence of Immunoglobulin E–Mediated Allergies in Children and Adolescents With Organ Transplants

  2006cites this paper
• Recent trends and directions in the rationalization of pharmacotherapy of bronchial asthma: probing for alternatives.

  2006cites this paper
• Uncontrolled asthma: a review of the prevalence, disease burden and options for treatment.

  2006cites this paper
• Vers une meilleure prise en charge des patients asthmatiques difficiles à contrôler

  2006cites this paper
• [Better management of patients with difficult asthma].

  2006cites this paper
• Targeting memory Th2 cells for the treatment of allergic asthma.

  2006cites this paper
• Opciones terapéuticas en el asma de difícil control

  2005cites this paper
• A Rational Approach to the Management of Severe Refractory Asthma

  2005cites this paper
• Benefits of omalizumab as add‐on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE

  2005cites this paper
• Immunosuppressive and Other Alternate Treatments for Asthma

  2005cites this paper
• Novel Anti-inflammatory Therapies

  2004cites this paper
• A new class of cyclosporin analogues for the treatment of asthma

  2003cites this paper
• The role of T lymphocytes in the pathogenesis of asthma.

  2003cites this paper
• A cyclosporin A/maltosyl-alpha-cyclodextrin complex for inhalation therapy of asthma.

  2003cites this paper
• Calcineurin antagonists differentially affect mediator secretion, p38 mitogen‐activated protein kinase and extracellular signal‐regulated kinases from immunologically activated human basophils

  2003cites this paper
• Alternate treatments in asthma.

  2003cites this paper
• A cyclosporin A/maltosyl‐α‐cyclodextrin complex for inhalation therapy of asthma

  2003cites this paper
• Cyclosporin A, apoptosis of BAL T‐cells and expression of Bcl‐2 inasthmatics

  2003cites this paper
• Pharmacology of airway inflammation in asthma and COPD.

  2003cites this paper
• Refractory asthma.

  2002cites this paper
• Asthma Refractory to Glucocorticoids

  2002cites this paper
• Development and Inhibition of Th2 Responses: Realization of Therapeutic Targets

  2002cites this paper
• Interleukin-5: a novel target for asthma therapy

  2001cites this paper
• Alternative agents in asthma.

  2001cites this paper
• Management of Severe Asthma

  2001cites this paper
• New treatments for asthma

  2000cites this paper
• Novel immunosuppressants in asthma.

  2000cites this paper
• Alternative strategies in the treatment of bronchial asthma

  2000cites this paper
• [Asthma and aspirin intolerance].

  2000cites this paper
• [Alternatives to standard therapy for bronchial asthma].

  2000cites this paper
• New directions in allergic diseases: mechanism-based anti-inflammatory therapies.

  2000cites this paper
• Cyclosporin as an oral corticosteroid sparing agent in stable asthma.

  2000cites this paper
• Differences in regulatory pathways identify subgroups of T cell‐derived Th2 cytokines

  2000cites this paper
• Steroid Sparing Therapies in Asthma

  2000cites this paper
• NEW TARGETS FOR FUTURE ASTHMA THERAPY

  2000cites this paper
• INHIBITORY ACTION OF CYCLOSPORIN D (CSD) ON IgE-MEDIATED DEGRANULATION IN RAT BASOPHILIC LEUKEMIA 2H3 CELLS

  2000cites this paper
• Alternativen zur Standardtherapie des Asthma bronchiale

  2000cites this paper
• Cytokines in asthma

  1999cites this paper
• Drug treatment of asthma in the 1990s: achievements and new strategies.

  1999cites this paper
• Aspirin-induced asthma: advances in pathogenesis and management.

  1999cites this paper
• Anti-T cell strategies in asthma

  1999cites this paper
• Fluticasone propionate powder: oral corticosteroid-sparing effect and improved lung function and quality of life in patients with severe chronic asthma.

  1999cites this paper
• ALTERNATIVE ANTI-INFLAMMATORY AND IMMUNOMODULATOR MEDICATIONS FOR ASTHMA

  1999cites this paper
• Therapeutic strategies for allergic diseases

  1999cites this paper
• Anti-Inflammatory Drugs in Asthma: The Pathophysiology of Asthma

  1999cites this paper
• Nebulizer-compatible liquid formulations for aerosol pulmonary delivery of hydrophobic drugs: glucocorticoids and cyclosporine.

  1999cites this paper
• Canadian Asthma Consensus Report, 1999. Canadian Asthma Consensus Group.

  1999cites this paper
• Newer therapeutic agents for asthma.

  1999cites this paper
• Role of IL–5 in the Development of Allergen–Induced Airway Hyperresponsiveness

  1999cites this paper
• 43 – Future Therapies for Asthma

  1998cites this paper
• Alternative treatments for difficult severe therapy-resistant asthma

  1998cites this paper
• T-Cells in the Pathogenesis of Asthma and Allergic Diseases

  1998cites this paper
• Cyclosporin A treatment and airways inflammation in corticosteroid‐dependent asthma

  1998influential citation
• Inflammatory mediators of asthma: an update.

  1998cites this paper
• Role of T cells in asthma.

  1998cites this paper
• T Lymphocytes in Chronic Asthma

  1998cites this paper
• Asthme chronique grave : place des traitements immunosuppresseurs

  1997cites this paper
• Immunosuppressive treatment in asthma.

  1997cites this paper
• New Therapies for Asthma

  1997cites this paper
• How Does Auranofin Compare with Methotrexate and Cyclosporin as a Corticosteroid-Sparing Agent in Severe Asthma?

  1997cites this paper